Johnson & Johnson (JNJ)
147.85
-0.68
(-0.46%)
USD |
NYSE |
Apr 25, 09:39
Johnson & Johnson Research and Development Expense (Annual): 15.08B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 15.08B |
| December 31, 2022 | 14.14B |
| December 31, 2021 | 14.28B |
| December 31, 2020 | 12.34B |
| December 31, 2019 | 11.36B |
| December 31, 2018 | 10.78B |
| December 31, 2017 | 10.59B |
| December 31, 2016 | 9.143B |
| December 31, 2015 | 9.046B |
| December 31, 2014 | 8.494B |
| December 31, 2013 | 8.183B |
| December 31, 2012 | 7.665B |
| December 31, 2011 | 7.548B |
| December 31, 2010 | 6.844B |
| December 31, 2009 | 6.986B |
| Date | Value |
|---|---|
| December 31, 2008 | 7.577B |
| December 31, 2007 | 7.68B |
| December 31, 2006 | 7.125B |
| December 31, 2005 | 6.462B |
| December 31, 2004 | 5.344B |
| December 31, 2003 | 4.684B |
| December 31, 2002 | 3.957B |
| December 31, 2001 | 3.591B |
| December 31, 2000 | 3.105B |
| December 31, 1999 | 2.768B |
| December 31, 1998 | 2.336B |
| December 31, 1997 | 2.14B |
| December 31, 1996 | |
| December 31, 1995 | |
| December 31, 1994 | 1.278B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
11.36B
Minimum
2019
15.08B
Maximum
2023
13.44B
Average
14.14B
Median
2022
Research and Development Expense (Annual) Benchmarks
| Amgen Inc | 4.784B |
| Gilead Sciences Inc | 5.718B |
| Eli Lilly and Co | 9.313B |
| Merck & Co Inc | 30.53B |
| Shockwave Medical Inc | 145.65M |